BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows in 2004. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2004-12-06: Reporting owner Dobroff Lawrence; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2004-02-26: Reporting owner Schamroth Michael; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2004-12-06 | Dobroff Lawrence Officer (Chief Financial Officer) | 5 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +958 958 owned after | $2.05 exercise price | 2007-02-14 | |
| 2004-02-26 | Schamroth Michael Director | 5 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.71 exercise price | 2006-10-10 |